A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection

Anticardiolipin antibodies (aCL) purified from patients with autoimmune disease have recently been shown to interact with a phospholipid-binding plasma protein, β2-glycoprotein I (β2-GPI). The aim of this study was to determine whether aCL purified from patients with infection also interact with β2 -GPI. aCL purified from 23 patients with malaria, infectious mononucleosis, tuberculosis, hepatitis A or syphilis did not require the presence of β2-GPI to bind cardiolipin (CL). In contrast, aCL were purified from 11 out of 12 patients with autoimmune disease that bound CL only in the presence of β2-GPI. Thrombotic complications appear to be associated with aCL occurring in autoimmune disease but not with aCL associated with infections. We postulate that this increased risk of thrombosis in the autoimmune group may be due to the presence of aCL that bind CL in association with β2-GPI, a plasma protein with anticoagulant activity.

[1]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[2]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[3]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[5]  C. Chesterman,et al.  Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics , 1989, British journal of haematology.

[6]  W. Irving,et al.  ANTI-CARDIOLIPIN ANTIBODIES IN VIRAL INFECTION , 1989, The Lancet.

[7]  C. Chesterman,et al.  Purification of antiphospholipid antibodies using a new affinity method. , 1988, Thrombosis Research.

[8]  C. Chesterman,et al.  Binding specificity of lupus anticoagulants and anticardiolipin antibodies. , 1988, Thrombosis research.

[9]  R. M. de Oliveira,et al.  Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis , 1988, American journal of hematology.

[10]  J. Goudevenos,et al.  High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. , 1987, Clinical and experimental immunology.

[11]  G. Hughes,et al.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. , 1987, Clinical and experimental immunology.

[12]  M. Druzin,et al.  Antibody to cardiolipin, lupus anticoagulant, and fetal death. , 1987, The Journal of rheumatology.

[13]  J. Nimpf,et al.  Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. , 1987, Atherosclerosis.

[14]  G. Hughes,et al.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.

[15]  P. Bomans,et al.  Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I , 1986 .

[16]  G. Hughes,et al.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody , 1985, British journal of haematology.

[17]  C. Mackworth-Young,et al.  ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1983, The Lancet.

[18]  J. Thorell,et al.  Enzymatic iodination of polypeptides with 125I to high specific activity. , 1971, Biochimica et biophysica acta.

[19]  C. Mohr,et al.  Biologically false positive serologic tests for syphilis; type, incidence, and cause. , 1952 .

[20]  M. C. Pangborn.  A New Serologically Active Phospholipid from Beef Heart , 1941 .

[21]  C. Chesterman,et al.  Immunology and clinical importance of antiphospholipid antibodies. , 1991, Advances in immunology.

[22]  G. Hughes,et al.  Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. , 1988, The Journal of infectious diseases.

[23]  P. Bomans,et al.  Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. , 1986, Biochimica et biophysica acta.

[24]  H. Wurm.  beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. , 1984, The International journal of biochemistry.